Insider Trading April 15, 2026 04:34 PM

Virtuix CEO Disposes $66,869 of VTIX Shares Amid Volatile Trading

Jan Roger Goetgeluk sold two blocks of Class A stock under a 10b5-1 plan as the company pursues military testing and board changes

By Hana Yamamoto VTIX
Virtuix CEO Disposes $66,869 of VTIX Shares Amid Volatile Trading
VTIX

Virtuix Holdings Inc Chief Executive Officer Jan Roger Goetgeluk sold a combined $66,869 of Class A common stock in two transactions on April 13-14, 2026, executed under a pre-arranged Rule 10b5-1 trading plan. The insider sales occurred while the stock has experienced significant volatility and a steep six-month decline. Separately, Virtuix is advancing testing and partnership initiatives for its Omni One virtual reality treadmill and has made board and warrant-related adjustments disclosed in SEC filings.

Key Points

  • CEO Jan Roger Goetgeluk sold a total of $66,869 in VTIX stock across two trades on April 13-14, 2026, under a Rule 10b5-1 plan; he retains direct ownership of 4,464,750 shares.
  • VTIX has experienced high price volatility, falling 74% in six months and trading about 93% below its 52-week peak of $92.74; InvestingPro flagged the stock as appearing overvalued at current levels and provided nine additional ProTips for investors.
  • Corporate developments include a Cooperative Research and Development Agreement with the Naval Postgraduate School to test the Omni One system for military training, an extension of a $6.00 warrant exercise price for 90 days for Streeterville Capital, and the appointment of Brett Moyer to the board; Virtuix is also collaborating with the University of Central Florida on a humanoid-robot control demonstration using the Omni One and vDen projection system.

Virtuix Holdings Inc (NASDAQ:VTIX) Chief Executive Officer Jan Roger Goetgeluk completed two separate stock sales totaling $66,869 in mid-April 2026. According to disclosures, Goetgeluk sold 3,842 shares of Class A common stock on April 13, 2026, at $6.17 per share, and on April 14, 2026, he sold 6,713 shares at $6.43 per share.

The company filing states these transactions were carried out under a pre-arranged Rule 10b5-1 trading plan. After these dispositions, Goetgeluk is reported to directly hold 4,464,750 shares of Virtuix Holdings.

Those insider moves come as VTIX shares have shown pronounced price swings. The stock has declined 74% over the past six months and is trading approximately 93% below its 52-week high of $92.74. An InvestingPro analysis cited in company reporting indicates the shares appear overvalued at current levels and the platform lists nine additional ProTips for investors assessing the company.


Beyond the equity transactions, Virtuix has disclosed several operational and governance developments. The Austin-based firm signed a Cooperative Research and Development Agreement with the Naval Postgraduate School to evaluate its Omni One virtual reality system for military training applications. The agreement is intended to test the company’s omni-directional navigation technology in training and simulation tasks.

Virtuix also disclosed an extension of a reduced exercise price period for a set of warrants held by Streeterville Capital, LLC. Under the SEC filing, the exercise price for those warrants remains fixed at $6.00 per share for an additional 90 days.

On the governance front, Brett Moyer has been appointed to Virtuix’s board of directors. The filing notes Moyer most recently served as Chief Financial Officer of Datavault AI and was a founding member of WiSA Technologies, underscoring experience in executive financial leadership and earlier industry ventures.

In another technical collaboration, Virtuix is working with the University of Central Florida’s Institute for Simulation & Training to demonstrate real-time humanoid robot control using the Omni One treadmill. The project will show how a human operator can direct a humanoid robot’s motions while viewing the environment through the vDen stereoscopic projection system.


Collectively, the disclosures cover insider selling, equity-holder arrangements, a research partnership with a military academic institution, a board appointment, and an academic demonstration linking Virtuix’s treadmill to humanoid robotics. The filings present a mix of financial maneuvers and product-development efforts occurring while the company’s share price has been under significant pressure.

Risks

  • Continued share-price volatility and the recent 74% decline over six months could affect investor confidence and market valuation - impacting technology and small-cap equities.
  • The extension of the reduced warrant exercise price for Streeterville Capital may lead to potential dilution if the warrants are exercised, creating downward pressure on shares - relevant to existing shareholders and capital markets.
  • Results from experimental and research agreements, such as the Naval Postgraduate School testing of Omni One and the UCF humanoid demonstration, are uncertain and may influence commercial adoption timelines for simulation and robotics applications - affecting defense and simulation technology markets.

More from Insider Trading

JPMorgan Co-CEO Douglas Petno Sells $1.7 Million in Stock Apr 15, 2026 JPMorgan Executive Disposes $1.97 Million in Stock as Bank Nears $38 Billion Loan Close for Oracle Apr 15, 2026 JPMorgan Asset & Wealth CEO Sells $3.78 Million in Stock Apr 15, 2026 JPMorgan CIO Disposes $970,659 in Stock; Bank Involved in $38B Oracle Loan Package Apr 15, 2026 Strategy Inc Director Patten Disposes $444,193 in Class A Shares, Simultaneously Exercises Options Apr 15, 2026